{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T21:23:21Z","timestamp":1787261001290,"version":"build-2736575974"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T00:00:00Z","timestamp":1784764800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100009232","name":"Beatson Cancer Charity","doi-asserted-by":"publisher","award":["20\\u201321-034"],"award-info":[{"award-number":["20\\u201321-034"]}],"id":[{"id":"10.13039\/100009232","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ctro.science","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical and Translational Radiation Oncology"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.ctro.2026.101245","type":"journal-article","created":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T06:55:39Z","timestamp":1784962539000},"page":"101245","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Biologically adaptive radiotherapy for oropharyngeal Cancer (BARitOne): An R-IDEAL stage 2a-2b technical optimisation, feasibility, and safety study \u2013 Study protocol"],"prefix":"10.1016","volume":"60","author":[{"given":"S.","family":"Anderson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.C.","family":"Douglas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Valentine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Grocutt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.J.","family":"Inman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Hay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Wright","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Mair","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Kelly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Seddon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Shaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MacMillan","family":"A","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Gourlay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Flach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Au","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Vens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Schoenherr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Grose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Lamb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Schipani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Vohra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Paterson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ctro.2026.101245_bb0005","series-title":"UK head and neck cancer stats at a glance","author":"CRUK","year":"2025"},{"issue":"22","key":"10.1016\/j.ctro.2026.101245_bb0010","doi-asserted-by":"crossref","first-page":"6598","DOI":"10.1158\/0008-5472.CAN-16-0633","article-title":"HPV-related oropharynx Cancer in the United Kingdom: an evolution in the understanding of disease etiology","volume":"76","author":"Schache","year":"2016","journal-title":"Cancer Res"},{"issue":"5","key":"10.1016\/j.ctro.2026.101245_bb0015","doi-asserted-by":"crossref","first-page":"E255","DOI":"10.1016\/S1473-3099(25)00181-1","article-title":"Rapidly rising rates of oropharyngeal cancer and economic burden in the UK","volume":"25","author":"Rehman","year":"2025","journal-title":"Lancet Infect Dis"},{"issue":"1","key":"10.1016\/j.ctro.2026.101245_bb0020","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1056\/NEJMoa0912217","article-title":"Human papillomavirus and survival of patients with oropharyngeal cancer","volume":"363","author":"Ang","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ctro.2026.101245_bb0025","first-page":"4","article-title":"Treatment de-escalation for HPV-driven oropharyngeal cancer: where do we stand?","volume":"8","author":"Mirghani","year":"2017","journal-title":"Clin Transl Radiat Oncol"},{"issue":"1","key":"10.1016\/j.ctro.2026.101245_bb0030","doi-asserted-by":"crossref","first-page":"10869","DOI":"10.1038\/s41467-024-55203-z","article-title":"Molecular correlates for HPV-negative head and neck cancer engraftment prognosticate patient outcomes","volume":"15","author":"Waas","year":"2024","journal-title":"Nat Commun"},{"issue":"10166","key":"10.1016\/j.ctro.2026.101245_bb0035","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/S0140-6736(18)32779-X","article-title":"Radiotherapy plus cetuximab or cisplatin in human papillomavirus-positive oropharyngeal cancer (NRG oncology RTOG 1016): a randomised, multicentre, non-inferiority trial","volume":"393","author":"Gillison","year":"2019","journal-title":"Lancet"},{"issue":"10166","key":"10.1016\/j.ctro.2026.101245_bb0040","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0140-6736(18)32752-1","article-title":"Radiotherapy plus cisplatin or cetuximab in low-risk human papillomavirus-positive oropharyngeal cancer (De-ESCALaTE HPV): an open-label randomised controlled phase 3 trial","volume":"393","author":"Mehanna","year":"2019","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.ctro.2026.101245_bb0045","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1200\/JCO.20.02072","article-title":"ARTSCAN III: a randomized phase III study comparing Chemoradiotherapy with cisplatin versus Cetuximab in patients with Locoregionally advanced Head and neck squamous cell Cancer","volume":"39","author":"Gebre-Medhin","year":"2021","journal-title":"J Clin Oncol"},{"issue":"2","key":"10.1016\/j.ctro.2026.101245_bb0050","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.semradonc.2025.01.004","article-title":"De-escalated Management of HPV-positive oropharyngeal carcinoma: improving outcomes with personalized approaches","volume":"35","author":"Yacoub","year":"2025","journal-title":"Semin Radiat Oncol"},{"issue":"8","key":"10.1016\/j.ctro.2026.101245_bb0055","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1200\/JCO.23.01308","article-title":"Hypoxia-directed treatment of human papillomavirus-related oropharyngeal carcinoma","volume":"42","author":"Lee","year":"2024","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ctro.2026.101245_bb0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.annonc.2025.08.1949","article-title":"1317O results from CompARE phase III RCT: neoadjuvant durvalumab plus chemoradiotherapy (CRT) followed by adjuvant durvalumab immunotherapy (IO) vs CRT alone in intermediate and high-risk oropharyngeal cancer (OPC)","author":"Mehanna","year":"2025","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ctro.2026.101245_bb0065","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.ejca.2021.05.021","article-title":"Dose-escalated intensity-modulated radiotherapy in patients with locally advanced laryngeal and hypopharyngeal cancers: ART DECO, a phase III randomised controlled trial","volume":"153","author":"Nutting","year":"2021","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ctro.2026.101245_bb0070","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.radonc.2021.01.013","article-title":"Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): an update on 107 randomized trials and 19,805 patients, on behalf of MACH-NC group","volume":"156","author":"Lacas","year":"2021","journal-title":"Radiother Oncol"},{"issue":"2","key":"10.1016\/j.ctro.2026.101245_bb0075","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1002\/hed.70047","article-title":"Clinical outcomes of radiologically node-negative oropharyngeal squamous cell carcinoma: a retrospective analysis","volume":"48","author":"Elmarghani","year":"2026","journal-title":"Head Neck"},{"issue":"4","key":"10.1016\/j.ctro.2026.101245_bb0080","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1002\/hed.25543","article-title":"Association between comorbidity and survival in head and neck cancer: results from Head and neck 5000","volume":"41","author":"Schimansky","year":"2019","journal-title":"Head Neck"},{"issue":"4","key":"10.1016\/j.ctro.2026.101245_bb0085","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1002\/hed.26589","article-title":"Inequality in survival of people with head and neck cancer: Head and neck 5000 cohort study","volume":"43","author":"Ingarfield","year":"2021","journal-title":"Head Neck"},{"key":"10.1016\/j.ctro.2026.101245_bb0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.ctrv.2023.102585","article-title":"Managing cisplatin-ineligible patients with resected, high-risk, locally advanced squamous cell carcinoma of the head and neck: is there a standard of care?","volume":"119","author":"Haddad","year":"2023","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/j.ctro.2026.101245_bb0095","doi-asserted-by":"crossref","DOI":"10.1038\/s41572-020-00224-3","article-title":"Head and neck squamous cell carcinoma","author":"Johnson","year":"2020","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.ctro.2026.101245_bb0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.oraloncology.2020.105140","article-title":"Improved survival prediction for oropharyngeal cancer beyond TNMv8","volume":"115","author":"Price","year":"2021","journal-title":"Oral Oncol"},{"issue":"S1","key":"10.1016\/j.ctro.2026.101245_bb0105","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1017\/S0022215123001615","article-title":"Head and neck cancer: United Kingdom National Multidisciplinary Guidelines, sixth edition","volume":"138","author":"Homer","year":"2024","journal-title":"J Laryngol Otol"},{"issue":"1","key":"10.1016\/j.ctro.2026.101245_bb0110","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1002\/hed.70005","article-title":"Does modified 5-item frailty index correlate with survival in oropharyngeal squamous cell carcinoma?","volume":"48","author":"Chmielecka","year":"2026","journal-title":"Head Neck"},{"issue":"4","key":"10.1016\/j.ctro.2026.101245_bb0115","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1111\/coa.13732","article-title":"Sociodemographics and survival characteristics of 253 human papilloma virus-related oropropharyngeal cancer cases in Glasgow, Scotland - a retrospective analysis","volume":"46","author":"Leong","year":"2021","journal-title":"Clin Otolaryngol"},{"key":"10.1016\/j.ctro.2026.101245_bb0120","doi-asserted-by":"crossref","first-page":"104882","DOI":"10.1016\/j.oraloncology.2020.104882","article-title":"The role of concomitant chemoradiotherapy in AJCC 7th edition T1-2N1 oropharyngeal carcinoma in the human papillomavirus era","volume":"110","author":"Lu","year":"2020","journal-title":"Oral Oncol"},{"issue":"1","key":"10.1016\/j.ctro.2026.101245_bb0125","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.radonc.2007.07.011","article-title":"A phase I study of dose-escalated chemoradiation with accelerated intensity modulated radiotherapy in locally advanced head and neck cancer","volume":"85","author":"Guerrero Urbano","year":"2007","journal-title":"Radiother Oncol"},{"issue":"3","key":"10.1016\/j.ctro.2026.101245_bb0130","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.radonc.2013.03.002","article-title":"A dose escalation study with intensity modulated radiation therapy (IMRT) in T2N0, T2N1, T3N0 squamous cell carcinomas (SCC) of the oropharynx, larynx and hypopharynx using a simultaneous integrated boost (SIB) approach","volume":"106","author":"Leclerc","year":"2013","journal-title":"Radiother Oncol"},{"issue":"1","key":"10.1016\/j.ctro.2026.101245_bb0135","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s13014-022-01991-x","article-title":"Adaptive dose escalated radiotherapy in oropharyngeal cancers: a treatment planning feasibility study","volume":"17","author":"Grocutt","year":"2022","journal-title":"Radiat Oncol"},{"issue":"2","key":"10.1016\/j.ctro.2026.101245_bb0140","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1080\/0284186X.2017.1364867","article-title":"Late mucosal ulcers in dose-escalated adaptive dose-painting treatments for head and neck cancer","volume":"57","author":"Olteanu","year":"2018","journal-title":"Acta Oncol"},{"key":"10.1016\/j.ctro.2026.101245_bb0145","series-title":"Recommendations for cross-sectional imaging in Cancer management","first-page":"pp14","article-title":"Head and neck cancers","author":"Olliff","year":"2014"},{"issue":"2","key":"10.1016\/j.ctro.2026.101245_bb0150","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1148\/radiology.168.2.3393671","article-title":"Separation of diffusion and perfusion in intravoxel incoherent motion MR imaging","volume":"168","author":"Le Bihan","year":"1988","journal-title":"Radiology"},{"issue":"1","key":"10.1016\/j.ctro.2026.101245_bb0155","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1102\/1470-7330.2010.0030","article-title":"Diffusion-weighted MRI in head and neck radiology: applications in oncology","volume":"10","author":"Thoeny","year":"2011","journal-title":"Cancer Imaging"},{"key":"10.1016\/j.ctro.2026.101245_bb0160","article-title":"Prospective validation of diffusion-weighted MRI as a biomarker of tumor response and oncologic outcomes in head and neck cancer: results from an observational biomarker pre-qualification study","volume":"183","author":"Joint Head and Neck Radiotherapy-MRI Development Cooperative","year":"2023","journal-title":"Radiother Oncol"},{"issue":"3","key":"10.1016\/j.ctro.2026.101245_bb0165","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1158\/1078-0432.CCR-08-1287","article-title":"Diffusion-weighted magnetic resonance imaging for predicting and detecting early response to chemoradiation therapy of squamous cell carcinomas of the head and neck","volume":"15","author":"Kim","year":"2009","journal-title":"Clin Cancer Res"},{"issue":"7","key":"10.1016\/j.ctro.2026.101245_bb0170","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1007\/s00330-010-1734-6","article-title":"Predictive value of diffusion-weighted magnetic resonance imaging during chemoradiotherapy for head and neck squamous cell carcinoma","volume":"20","author":"Vandecaveye","year":"2010","journal-title":"Eur Radiol"},{"issue":"9","key":"10.1016\/j.ctro.2026.101245_bb0175","doi-asserted-by":"crossref","first-page":"2213","DOI":"10.1007\/s00330-010-1769-8","article-title":"Squamous cell carcinoma of the head and neck: diffusion-weighted MR imaging for prediction and monitoring of treatment response","volume":"20","author":"King","year":"2010","journal-title":"Eur Radiol"},{"issue":"2","key":"10.1016\/j.ctro.2026.101245_bb0180","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1148\/radiol.12120167","article-title":"Head and neck squamous cell carcinoma: diagnostic performance of diffusion-weighted MR imaging for the prediction of treatment response","volume":"266","author":"King","year":"2013","journal-title":"Radiology"},{"key":"10.1016\/j.ctro.2026.101245_bb0185","first-page":"13","article-title":"Study of diffusion weighted MRI as a predictive biomarker of response during radiotherapy for high and intermediate risk squamous cell cancer of the oropharynx: the MeRInO study","volume":"2","author":"Paterson","year":"2017","journal-title":"Clin Transl Radiat Oncol"},{"issue":"5","key":"10.1016\/j.ctro.2026.101245_bb0190","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1007\/s00259-017-3890-2","article-title":"Changes in multimodality functional imaging parameters early during chemoradiation predict treatment response in patients with locally advanced head and neck cancer","volume":"45","author":"Wong","year":"2018","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"4","key":"10.1016\/j.ctro.2026.101245_bb0195","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1007\/s12663-016-0881-y","article-title":"Adaptive radiotherapy for Head neck Cancer","volume":"15","author":"Mali","year":"2016","journal-title":"J Maxillofac Oral Surg"},{"issue":"3","key":"10.1016\/j.ctro.2026.101245_bb0200","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.ijrobp.2014.05.044","article-title":"Traditional phase 1 and 2 studies in thoracic radiation oncology should be abandoned","volume":"90","author":"Faivre-Finn","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"9695","key":"10.1016\/j.ctro.2026.101245_bb0205","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1016\/S0140-6736(09)61083-7","article-title":"Evaluation and stages of surgical innovations","volume":"374","author":"Barkun","year":"2009","journal-title":"Lancet"},{"issue":"9695","key":"10.1016\/j.ctro.2026.101245_bb0210","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1016\/S0140-6736(09)61116-8","article-title":"No surgical innovation without evaluation: the IDEAL recommendations","volume":"374","author":"McCulloch","year":"2009","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.ctro.2026.101245_bb0215","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1016\/j.ijrobp.2020.12.015","article-title":"Initial feasibility and clinical implementation of daily MR-guided adaptive Head and neck Cancer radiation therapy on a 1.5T MR-Linac system: prospective R-IDEAL 2a\/2b systematic clinical evaluation of technical innovation","volume":"109","author":"McDonald","year":"2021","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ctro.2026.101245_bb0220","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2017.00059","article-title":"R-IDEAL: a framework for systematic clinical evaluation of technical innovations in radiation oncology","volume":"7","author":"Verkooijen","year":"2017","journal-title":"Front Oncol"},{"issue":"1","key":"10.1016\/j.ctro.2026.101245_bb0225","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.radonc.2013.10.010","article-title":"Delineation of the neck node levels for head and neck tumors: a 2013 update. DAHANCA, EORTC, HKNPCSG, NCIC CTG, NCRI, RTOG, TROG consensus guidelines","volume":"110","author":"Gr\u00e9goire","year":"2014","journal-title":"Radiother Oncol"},{"issue":"1","key":"10.1016\/j.ctro.2026.101245_bb0230","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.radonc.2017.10.016","volume":"126","author":"Gr\u00e9goire","year":"2018","journal-title":"Radiother Oncol"},{"issue":"1112","key":"10.1016\/j.ctro.2026.101245_bb0235","doi-asserted-by":"crossref","DOI":"10.1259\/bjr.20190250","article-title":"Radiobiologically derived biphasic fractionation schemes to overcome the effects of tumour hypoxia","volume":"93","author":"Joseph","year":"2020","journal-title":"Br J Radiol"},{"issue":"204","key":"10.1016\/j.ctro.2026.101245_bb0245","article-title":"Diffusion-weighted magnetic resonance imaging (DWMRI) of head and neck squamous cell carcinoma: could it be an imaging biomarker for prediction of response to chemoradiation therapy","volume":"51","author":"Khattab","year":"2020","journal-title":"Egypt J Radiol Nucl Med"}],"container-title":["Clinical and Translational Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405630826001400?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405630826001400?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T20:23:37Z","timestamp":1787257417000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405630826001400"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":48,"alternative-id":["S2405630826001400"],"URL":"https:\/\/doi.org\/10.1016\/j.ctro.2026.101245","relation":{},"ISSN":["2405-6308"],"issn-type":[{"value":"2405-6308","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Biologically adaptive radiotherapy for oropharyngeal Cancer (BARitOne): An R-IDEAL stage 2a-2b technical optimisation, feasibility, and safety study \u2013 Study protocol","name":"articletitle","label":"Article Title"},{"value":"Clinical and Translational Radiation Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ctro.2026.101245","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V. on behalf of European Society for Radiotherapy and Oncology.","name":"copyright","label":"Copyright"}],"article-number":"101245"}}